SLGL
What one share of Sol-Gel Technologies holds
Pharmaceutical Preparations
Sol-Gel Technologies’s numbers from its SEC filings, divided by its shares. Results cover the latest fiscal year to 2025-12-31; the balance sheet is as of 2025-12-31.
| Sales | $6.96 |
|---|---|
| Profit | −$2.20 |
| Capex (buildings and equipment) | $0.02 |
| Free cash flow | $0.10 |
| Cash and investments | $8.61 |
| Book value | $8.19 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2019 | $11.72 | −$12.60 | $0.31 | −$11.82 | — | $25.71 |
| 2020 | $3.89 | −$12.97 | $0.20 | −$11.38 | — | $22.11 |
| 2021 | $13.27 | $1.40 | $0.06 | −$3.32 | — | $24.04 |
| 2022 | $1.68 | −$6.45 | $0.07 | −$4.17 | — | $18.25 |
| 2023 | $0.57 | −$10.06 | $0.05 | −$6.59 | — | $13.87 |
| 2024 | $4.14 | −$3.80 | $0.00 | −$4.99 | — | $10.35 |
| 2025 | $6.96 | −$2.20 | $0.02 | $0.10 | — | $8.19 |